Skip to main content

Table 1 Demographic features

From: Efficacy and tolerability of α-galactosidase in treating gas-related symptoms in children: a randomized, double-blind, placebo controlled trial

Variable α-galactosidase placebo P
(N = 27) (N = 25)
Demographic data    
Gender: n (%)    
  male 11 (41%) 9 (36%) 0.73
  female 16 (59%) 16 (64%)
Age (yrs): n (%)    
  <8 12 (44%) 10 (40%) 0.75
  > = 8 15 (56%) 15 (60%)
Weight (kg): n (%)    
  ≤20 9 (33%) 7 (28%) 0.92
  >20, ≤40 7 (26%) 7 (28%)
  >40 11 (41%) 11 (44%)